These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36882839)

  • 21. Internal driveline damage under the costal margin several years after HeartMate II implant: a series of three cases.
    Ogawa M; Masood MF; Ewald GA; Vader JM; LaRue SJ; Cheng A; Balsara KR; Itoh A
    J Artif Organs; 2018 Sep; 21(3):359-362. PubMed ID: 29502323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved Approach With Subcostal Exchange of the HeartMate II Left Ventricular Assist Device: Difference in On and Off Pump?
    Gaffey AC; Chen CW; Chung JJ; Phillips E; Wald J; Williams ML; Low DW; Acker MA; Atluri P
    Ann Thorac Surg; 2017 Nov; 104(5):1540-1546. PubMed ID: 28760470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Device exchange from Heartmate II to HeartWare HVAD.
    Beaupre RA; Alnajar A; Sugiura T; Chou B; Lamba HK; Kurihara C; Kawabori M; Critsinelis AC; Santiago A; Morgan JA
    J Card Surg; 2019 Nov; 34(11):1204-1207. PubMed ID: 31478230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanical Device Malfunction of the HeartMate II Versus the HeartMate 3 Left Ventricular Assist Device: The Rotterdam Experience.
    van der Heiden CW; Zijderhand CF; Veen KM; Constantinescu AA; Manintveld OC; Brugts JJ; Bekkers JA; Birim O; Bogers AJJC; Caliskan K
    ASAIO J; 2023 Feb; 69(2):e80-e85. PubMed ID: 36516019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac recovery following left ventricular assist device therapy: experience of complete device explantation including ventricular patch plasty.
    Gyoten T; Rojas SV; Fox H; Hata M; Deutsch MA; Schramm R; Gummert JF; Morshuis M
    Eur J Cardiothorac Surg; 2021 Apr; 59(4):855-862. PubMed ID: 33367693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
    Uriel N; Colombo PC; Cleveland JC; Long JW; Salerno C; Goldstein DJ; Patel CB; Ewald GA; Tatooles AJ; Silvestry SC; John R; Caldeira C; Jeevanandam V; Boyle AJ; Sundareswaran KS; Sood P; Mehra MR
    Circulation; 2017 May; 135(21):2003-2012. PubMed ID: 28385948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One-year outcomes with the HeartMate 3 left ventricular assist device.
    Hanke JS; Dogan G; Zoch A; Ricklefs M; Wert L; Feldmann C; Bara C; Shrestha M; Tillmanns J; Kempf T; Bauersachs J; Haverich A; Schmitto JD
    J Thorac Cardiovasc Surg; 2018 Aug; 156(2):662-669. PubMed ID: 29525258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeat left ventricular-assisted device exchange and upgrade from second- to third-generation devices in a high-volume single center.
    Kassi M; Avenatti E; Hoang KD; Zook S; Yousafzai R; Guha A; Bhimaraj A; Chou LP; Suarez EE
    Artif Organs; 2024 May; 48(5):536-542. PubMed ID: 38189564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial.
    Bansal A; Uriel N; Colombo PC; Narisetty K; Long JW; Bhimaraj A; Cleveland JC; Goldstein DJ; Stulak JM; Najjar SS; Lanfear DE; Adler ED; Dembitsky WP; Somo SI; Crandall DL; Chen D; Connors JM; Mehra MR
    J Heart Lung Transplant; 2019 Aug; 38(8):806-816. PubMed ID: 31147187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. De Novo Human Leukocyte Antigen Allosensitization in Heartmate 3 Versus Heartmate II Left Ventricular Assist Device Recipients.
    Jain R; Habal MV; Clerkin KJ; Latif F; Restaino SW; Zorn E; Takeda K; Naka Y; Yuzefpolskaya M; Farr MA; Colombo PC; Sayer GT; Uriel N; Topkara VK
    ASAIO J; 2022 Feb; 68(2):226-232. PubMed ID: 33883507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left Ventricular Assist Device Flow Pattern Analysis Using a Novel Model Incorporating Left Ventricular Pulsatility.
    Grinstein J; Torii R; Bourantas CV; Garcia-Garcia HM
    ASAIO J; 2021 Jul; 67(7):724-732. PubMed ID: 33528162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices.
    John R; Kamdar F; Eckman P; Colvin-Adams M; Boyle A; Shumway S; Joyce L; Liao K
    Ann Thorac Surg; 2011 Nov; 92(5):1593-9; discussion 1599-600. PubMed ID: 22051256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.
    Mehra MR; Salerno C; Cleveland JC; Pinney S; Yuzefpolskaya M; Milano CA; Itoh A; Goldstein DJ; Uriel N; Gulati S; Pagani FD; John R; Adamson R; Bogaev R; Thohan V; Chuang J; Sood P; Goates S; Silvestry SC
    Circulation; 2018 Oct; 138(18):1923-1934. PubMed ID: 29807933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complex HeartMate II infection treated with pump exchange to HeartWare HVAD.
    Abicht T; Gordon R; Meehan K; Stosor V; McCarthy P; McGee E
    ASAIO J; 2013; 59(2):188-92. PubMed ID: 23438785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial.
    Patel CB; Blue L; Cagliostro B; Bailey SH; Entwistle JW; John R; Thohan V; Cleveland JC; Goldstein DJ; Uriel N; Su X; Somo SI; Sood P; Mehra MR
    J Heart Lung Transplant; 2020 Aug; 39(8):774-781. PubMed ID: 32276809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initial experience with routine less invasive implantation of HeartMate II left ventricular assist device without median sternotomy.
    Anyanwu AC; Itagaki S; Pinney S; Adams DH
    Eur J Cardiothorac Surg; 2014 Dec; 46(6):985-90. PubMed ID: 24623169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous Driveline Fracture After Implantation of the HeartMate II Left Ventricular Assist Device: How Durable is Driveline Repair?
    Stulak JM; Schettle S; Haglund N; Dunlay S; Cowger J; Shah P; Aaronson KD; Pagani FD; Maltais S
    ASAIO J; 2017; 63(5):542-545. PubMed ID: 28125463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of cardiac computed tomography for inflow cannula patency assessment and prediction of clinical outcome in patients with the HeartMate II left ventricular assist device.
    Sacks J; Gonzalez-Stawinski GV; Hall S; Lima B; MacHannaford J; Dockery W; Cura M; Chamogeorgakis T
    Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):590-3. PubMed ID: 26223857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term single-centre experience with the HeartMate 3 left ventricular assist device for advanced heart failure.
    Nowacka A; Hullin R; Tozzi P; Barras N; Regamey J; Yerly P; Rosner L; Marcucci C; Rusca M; Liaudet L; Kirsch M
    Eur J Cardiothorac Surg; 2020 Sep; 58(3):511-518. PubMed ID: 32236472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.